申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP1785426A1
公开(公告)日:2007-05-16
A carbapenem compound represented by a following formula [1],
wherein R1 is C1 to C3 alkyl or C1 to C3 alkyl substituted by hydroxy. R is hydrogen atom or a group which regenerates a carboxyl group by hydrolysis in a living body,
A is a following formula [1a],
wherein E is a 5 to 7 membered cyclic ring optionally containing 1 to 3 hetero atoms (excluding benzene ring) which forms a bicyclic ring in corporation with the benzene ring,
Y is hydrogen atom, C1 to C4 alkyl, C1 to C4 alkoxy, trifluoromethoxy, halogen atom or cyano group,
or its pharmaceutically acceptable salt.
由下式[1]表示的碳青霉烯类化合物、
其中 R1 是 C1 至 C3 烷基或被羟基取代的 C1 至 C3 烷基。R 是氢原子或在活体内通过水解再生出羧基的基团、
A 为下式[1a]、
其中,E 是可选含有 1 至 3 个杂质原子(不包括苯环)的 5 至 7 个成员的环,它与苯环一起形成双环、
Y 是氢原子、C1 至 C4 烷基、C1 至 C4 烷氧基、三氟甲氧基、卤素原子或氰基、
或其药学上可接受的盐。